NFNilshan Fernando

Nilshan Fernando

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nilshan Fernando has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MRI diagnosis of an isolated encephalopathy

    by Nilshan Fernando, Daniel Ong, Yogesh Sharma

    Given the combination of fever and severe encephalopathy with no obvious cause, we suspected central nervous system infection and started empiric ceftriaxone, benzylpenicillin and acyclovir. Lumbar puncture was deferred because of the low GCS, technical difficulties with positioning and family wishes to avoid invasive procedures. Despite treatment, she deteriorated over the next 24 hours, her GCS score falling …

  • Open Access

    Application of HEART, GRACE 2.0 and TIMI scores for risk stratification of chest pain: a single-centre external pilot study in a Sri Lankan population

    by C. Welhenge, K. M. Fernando, J. N. Fernando, P. C. Deshapriya, M. L. D. Lekamge, A. Kasturiratne, A. P. De Silva

    HEART score is widely used for risk stratification in patients with chest pain. TIMI and GRACE 2.0 scores are recommended for prognostication in patients w

  • Open Access

    Evaluation of HEART score, GRACE 2.0 score, and TIMI score for Risk Stratification in Acute Coronary Syndrome: A Single-Centre Pilot Study in a Sri Lankan Population

    by Chiranthi Welhenge, Km Fernando, Jn Fernando, Pc Deshapriya, Mld Lekamge, A Kasturiratne, AP De Silva, Kavindya Fernando, Nilshan Fernando, Dilakshi Lekamge, et al.

    Objectives: HEART score is widely used for risk stratification, in patients with chest pain, to rule out acute coronary syndrome (ACS). Although limited, it has been validated in several countries throughout the world. TIMI and GRACE 2.0 scores are recommended for prognostication in patients with ACS. This study aimed to explore the effectiveness of HEART score, in a Sri Lankan population, for risk stratification, in patients presenting with chest pain and to compare its performance with GRACE 2.0 and TIMI scores. Methods: Data was collected from 74 patients presenting to the emergency department at a tertiary care centre in Sri Lanka. HEART, GRACE 2.0 and TIMI scores were calculated for each patient separately. The predictive accuracy of the HEART score with a diagnosis of ACS and the occurrence of major adverse cardiac events (MACE) at 6 weeks was assessed and compared with TIMI and GRACE 2.0. scores. Results: Area under receiver operating curve (AUC-ROC) for HEART, GRACE 2.0 and TIMI, for a diagnosis of ACS, were 0.889 (95% CI: 0.8171 - 0.9609), 0.805 (95% CI: 0.6758 - 0.9349), 0.812 (95% CI: 0.6961 - 0.9278) respectively. Delong’s test did not indicate a significant pairwise difference in scores. AUC-ROC for occurrence of MACE were 0.905 (95% CI: 0.8437 - 0.9669), 0.721 (95% CI: 0.5934 – 0.8493) and 0.767 (95% CI: 0.6467 – 0.888), for HEART, GRACE 2.0 and TIMI scores respectively, and these differences were statistically significant. Conclusions: HEART score is an effective score which can be used in Sri Lankans, in predicting the probability of ACS, and MACE within 6 weeks, in patients presenting with chest pain. It is comparable to GRACE 2.0 and TIMI scores in diagnostic accuracy while it is superior to GRACE and TIMI scores in predictive accuracy for short term risk of MACE.

  • Open Access

    Validity of the “HEART” Score as an Early Assessment Tool in Acute Coronary Syndrome in a Sri Lankan Population: A Single Centre Pilot Study

    by Chiranthi Welhenge, Km Fernando, Jn Fernando, Pc Deshapriya, Mld Lekamge, A Kasturiratne, AP De Silva, Kavindya Fernando, Nilshan Fernando, Dilakshi Lekamge, et al.

    Objectives: The HEART score is a clinical tool used for early risk stratification in patients presenting with chest pain in emergency settings, which facilitates prognostication. Although limited, it has been validated in several countries throughout the world. This study aimed to assess the validity of HEART score, in a Sri Lankan population, as an early assessment tool, for risk prediction of acute coronary syndrome (ACS), in patients presenting with chest pain. Methods: Data was collected from 74 patients presenting to the emergency department at a tertiary care centre in Sri Lanka. HEART score was calculated for each patient retrospectively and patients were categorized into low (0-3), intermediate (4-6), and high (7-10) risk groups. The predictive accuracy of the HEART score with a diagnosis of ACS and the occurrence of major adverse cardiac events (MACE) at 6 weeks was assessed. Statistical analysis was performed using R studio. Results: All patients in the low-risk group (n=8) were correctly identified as non-ACS, with no MACE. All high-risk patients (n=29) had ACS and experienced MACE. Among the intermediate risk group (n=37), 70.3% were diagnosed with ACS and 54% developed MACE at 6 weeks. Area under curve (AUC) for HEART score for a diagnosis of ACS, was 0.889 (95% CI: 0.8171-0.9609) while the AUC for occurrence of MACE was 0.9053 (95% CI: 0.8437 - 0.9669). Conclusions: The HEART score is an effective early assessment tool which can be used in Sri Lankans, in prediction of the probability of ACS, and MACE within 6 weeks, in patients presenting with chest pain.

  • Open Access

    Efficacy, Safety and Cost-effectiveness of Atorvastatin 40mg versus 80 mg in South Asian Patients with acute coronary syndrome: A protocol for randomised clinical trial

    by Kavindya Fernando, Nilshan Fernando, Chiranthi Welhenge, Shashima Liyanage, B.K.T.P. Dayanath, Shamila De Silva, Chamila Mettananda

    Introduction: Most guidelines recommend high-intensity statins for the secondary prevention of Acute Coronary Syndrome (ACS). However, it has been observed that South Asians are responsive to lower doses of statins to achieve the recommended target levels of low-density lipoprotein cholesterol (LDL-C). However, published data on this subject is limited. Therefore, we aim to compare the efficacy, safety and cost effectiveness of atorvastatin doses (80mg vs 40mg) in lowering the LDL-c levels to the less than 70 mg/dL within 12 weeks, among patients with incident ACS. Methods and analysis: This single-centre, prospective, randomised, controlled, open-labelled clinical trial is being conducted among patients naïve for statins presenting with incident ACS to the Colombo North Teaching Hospital, Ragama, Sri Lanka. All participants are randomised to two groups, to receive oral atorvastatin 40 mg nocte, or 80 mg nocte. The percentage of patients achieving treatment goals, the percentage with statin induced adverse drug reactions and the mean cost to achieve treatment goals will be compared between the two groups in 6,12 and 24 weeks. Outcome will be analysed for the intention-to-treat population. Ethics and dissemination: Ethical approval for this study has been obtained from the Ethics Review Committee of the Faculty of Medicine, University of Kelaniya (P/28/05/2022). This trial is registered in the Sri Lanka Clinical Trial Registry (SLCTR/2023/003). The results from this study will be disseminated as scientific publications in reputed journals. Key points of this study: What is already known on this topic? While the European guideline recommendation is to initiate atorvastatin at 80 mg dose for ACS, it has been observed that South Asians respond well to lower dose. Additionally, South Asians tend to experience more adverse effects with higher doses of statins. However, reports on differential action of atorvastatin in South Asians is limited. What this study adds?: This study explores the efficacy, safety, and cost-effectiveness of a lower dose of atorvastatin (40 mg daily) compared to guideline recommended dose of 80mg in a South Asian cohort. How might this study affect research, practice or policy?: The findings may influence statin dose recommendation for South Asians/Sri Lankans which will help to reduce unnecessary side effects and be cost saving as well in secondary prevention of ACS.

  • Open Access

    Borderline lepromatous leprosy: A case report

    by Nilshan Fernando, Chiranthi Welhenge, Ranjan Premaratna, Ahamed Uwyse

    Rationale: Lepromatous leprosy can have many atypical presentations, obscuring early diagnosis. We present a case of lepromatous leprosy, presenting with atypical features, which made a diagnostic dilemma. Patient concerns: A 48-year-old man presented with bilateral lower limb oedema and scaly “ichthyosis like” skin rash in both hands and feet, hepatosplenomegaly and pancytopenia, over a course of three months, without any classical features of leprosy. A skin biopsy revealed an unexpected diagnosis of borderline lepromatous leprosy. Diagnosis: Lepromatous leprosy. Interventions: Multi-drug regimen treatment with rifampicin, dapsone and clofazimine for lepromatous leprosy. Outcomes: The patient made a good clinical recovery. Lessons: In endemic settings, clinicians should be aware of similar atypical manifestations of leprosy to face the global challenge of eradicating this chronic deforming disease.


  • Open Access

    A Case Report of Acute Oxidative Haemolysis Following Medicinal Plant Ingestion in a Patient with G6PD Deficiency

    by Nilshan Fernando, Kavindya Fernando, Senani Williams, Anuja Premawardhena

    Introduction Acalypha indica (AI) is an Ayurvedic medicinal plant. Some of this plant’s phytochemicals have been reported to cause oxidative stress in red blood cells. However, we know very little about those chemicals due to a dearth of literature. We present a case in which a patient with a previously unidentified glucose-6-phosphate dehydrogenase (G6PD) deficiency experienced acute hemolysis after ingesting fresh AI plant leaves. Case Presentation A 65-year-old man presented with jaundice, pallor, and haematuria following ingestion of the "Kuppamenia mallum" dish. His peripheral blood picture showed bite cells and Heinz bodies. A positive Brewer's test raised the clinical suspicion of G6PD deficiency. Low values of the G6PD level assessment at the follow-up visit confirmed the diagnosis. Conclusion Although AI is regarded as a medicinal plant, acute hemolysis can also occur after consumption in G6PD-deficient patients. This case emphasises the need for further research to identify the phytochemicals and their concentrations that can induce toxicity.


  • Open Access

    Knowledge of the high-sensitivity cardiac troponin assay among medical officers in Gampaha District, Sri Lanka

    by N. Fernando, K. Fernando, T. Gallage, B. K. T. P. Dayanath, S. T. De Silva

    Introduction: The high-sensitivity cardiac troponin (hs-cTn) assay is a crucial diagnostic test that is obligatory in the triage of patients presenting with chest pain. It is essential for medical officers to have adequate knowledge regarding the procedures for testing and the interpretation of test outcomes to deliver optimal healthcare for patients. It has been observed that medical officers are lacking in awareness regarding this testing method, resulting in a greater likelihood of errors in testing and interpretation. This study aims to evaluate the level of understanding among medical officers regarding the hs-cTn assay in relation to the most recent European Society of Cardiology guideline released in 2020.Methodology: We conducted a cross-sectional study at two government hospitals in Gampaha District in June 2022. A self-administered e-questionnaire was used to assess knowledge regarding hs-cTn. Knowledge was measured by calculating a cumulative score for the answers to a questionnaire and categorised into good or poor knowledge. A score less than 60% was categorized as poor and vice versa. Descriptive statistics were used to summarize the data.Results: Of the 227 medical officers, only 14.5% (n=33) had good knowledge of the analytical component while 41.9% (n=95) had good knowledge on the clinical component. A score ≥60% on the analytical component knowledge was significantly associated with designation being a senior registrar or consultant (p<0.001), postgraduate enrolment (p<0.001), participation in continuous professional development programmes (p<0.001), and employment in a teaching hospital (p=0.025), but not with age (p=0.066) or private practice (p=0.118). Clinical component knowledge score ≥60% was significantly associated with age between 25 and 35 years (p=0.006), designation being a consultant (p<0.001), postgraduate enrolment (p<0.001), participation in continuous professional development programs (p<0.001), and employment in a teaching hospital(p=0.001) but not with doing private practice (p=0.170).Conclusions: In Sri Lanka, medical officers’ general knowledge on the hs-cTn assay seems lacking. There is a need for continuous training to improve knowledge on hs-cTn testing among medical officers.

  • Open Access

    Azygous anterior cerebral artery infarction

    by Nilshan Fernando, Udaya Ranawaka